<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">PROPOFOL</span><br/>(pro'po-fol)<br/><span class="topboxtradename">Diprivan<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent, general anesthesia</span>; <span class="classification">sedative-hypnotic</span><br/><b>Prototype: </b>Thiopental<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>10 mg/mL injection</p>
<h1><a name="action">Actions</a></h1>
<p>Sedative-hypnotic used in the induction and maintenance of anesthesia or sedation.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Rapid onset (40 sec) and minimal excitation during induction of anesthesia.</p>
<h1><a name="uses">Uses</a></h1>
<p>Induction or maintenance of anesthesia as part of a balanced anesthesia technique; conscious sedation in mechanically ventilated
         patients.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to propofol or propofol emulsion, which contain soybean oil and egg phosphatide; obstetrical procedures;
         patients with increased intracranial pressure or impaired cerebral circulation; pregnancy (category B), lactation. Do not
         use for conscious sedation in children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Patients with severe cardiac or respiratory disorders or history of epilepsy or seizures.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Induction of Anesthesia</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IV</span> 22.5 mg/kg q10sec until induction onset<br/><span class="rdage">Geriatric:</span> <span class="rdroute">IV</span> 11.5 mg/kg q10sec until induction onset<br/><span class="rdage">Child:</span> <span class="rdroute">IV</span> <img src="../images/special/greaterorequal.gif"/><i>3 y</i>, 2.53.5 mg/kg over 2030 sec<br/><br/><span class="indicationtitle">Maintenance of Anesthesia</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IV</span> 100200 mcg/kg/min<br/><span class="rdage">Geriatric:</span> <span class="rdroute">IV</span> 50100 mcg/kg/min<br/><span class="rdage">Child:</span> <span class="rdroute">IV</span> <img src="../images/special/greaterorequal.gif"/><i>3 y</i>, 125300 mcg/kg/min<br/><br/><span class="indicationtitle">Conscious Sedation</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IV</span> 5 mcg/kg/min for at least 5 min, may increase by 510 mcg/kg/min q510 min until desired level of sedation is achieved
               (may need maintenance rate of 550 mcg/kg/min)<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1>
<ul>
<li>Use strict aseptic technique to prepare propofol for injection; drug emulsion supports rapid growth of microorganisms.</li>
<li>Inspect ampuls and vials for particulate matter and discoloration. Discard if either is noted.</li>
<li>Shake well before use. Inspect for separation of the emulsion. Do not use if there is evidence of separation of phases of
            the emulsion.
         </li>
</ul>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravenous</span><p><span class="routemethod">PREPARE:</span> <span class="methodtype">IV Infusion:</span> Give undiluted or diluted in D5W to a concentration not less than 2 mg/mL. Must draw up into a sterile syringe immediately
                  after ampules or vials are opened. Begin drug administration immediately and completed within 6 h.  
               </p>
<p><span class="routemethod">ADMINISTER:</span> <span class="methodtype">IV Infusion:</span> Use syringe or volumetric pump to control rate. Determine rate by weight. Administer immediately after spiking the vial. Complete
                  infusion within 6 h.  
               </p>
<p><span class="routemethod">INCOMPATIBILITIES</span> <span class="incompattype"> Y-site:</span>
<b>Amikacin,</b>
<b>amphotericin B,</b>
<b>atracurium,</b>
<b>bretylium,</b>
<b>calcium chloride,</b>
<b>ciprofloxacin,</b>
<b>diazepam,</b>
<b>digoxin,</b>
<b>doxorubicin,</b>
<b>gentamicin,</b>
<b>methotrexate,</b>
<b>methylprednisolone,</b>
<b>metoclopramide,</b>
<b>minocycline,</b>
<b>mitoxantrone,</b>
<b>netilmicin,</b>
<b>phenytoin,</b>
<b>tobramycin,</b>
<b>verapamil.</b>
</p>
</td>
</tr>
</table>
<ul>
<li>Store unopened between 4° C (40° F) and 22° C (72° F). Refrigeration is not recommended. Protect from
            light.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Headache, dizziness, <span class="speceff-common">twitching, bucking, jerking, thrashing, clonic/myoclonic movements.</span>
<span class="typehead">Special Senses:</span> Decreased intraocular pressure. <span class="typehead">CV:</span> Hypotension, <span class="speceff-life">ventricular asystole</span> (rare). <span class="typehead">GI:</span> Vomiting, abdominal cramping. <span class="typehead">Respiratory:</span> Cough, hiccups, apnea. <span class="typehead">Other:</span> Pain at injection site. 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>Propofol produces a temporary reduction in <span class="alt">serum cortisol levels.</span> However, propofol does not seem to inhibit adrenal responsiveness to <span class="alt">ACTH.</span>
</p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead"> Drug:</span> Concurrent continuous infusions of propofol and <b>alfentanil</b> produce higher plasma levels of <b>alfentanil</b> than expected. <span class="classification">cns depressants</span> cause additive CNS depression. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Onset:</span> 936 sec. <span class="typehead">Duration:</span> 610 min. <span class="typehead">Distribution:</span> Highly lipophilic, crosses placenta, excreted in breast milk. <span class="typehead">Metabolism:</span> Extensively metabolized in the liver. <span class="typehead">Elimination:</span> Approximately 88% of the dose is recovered in the urine as metabolites. <span class="typehead">Half-Life:</span> 512 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor hemodynamic status and assess for dose-related hypotension.</li>
<li>Take seizure precautions. Tonic-clonic seizures have occurred following general anesthesia with propafol.</li>
<li>Be alert to the potential for drug induced excitation (e.g., twitching, tremor, hyperclonus) and take appropriate safety measures.</li>
<li>Provide comfort measures; pain at the injection site is quite common especially when small veins are used.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>